Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Jefferies Financial Group
JEF
|
+$460M |
| 2 |
Palo Alto Networks
PANW
|
+$363M |
| 3 |
State Street SPDR S&P Biotech ETF
XBI
|
+$330M |
| 4 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$291M |
| 5 |
iShares China Large-Cap ETF
FXI
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Caterpillar
CAT
|
+$755M |
| 2 |
Microsoft
MSFT
|
+$674M |
| 3 |
Apple
AAPL
|
+$642M |
| 4 |
Flutter Entertainment
FLUT
|
+$572M |
| 5 |
NVIDIA
NVDA
|
+$512M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.64% |
| 2 | Consumer Discretionary | 7.06% |
| 3 | Financials | 6.47% |
| 4 | Healthcare | 4.72% |
| 5 | Communication Services | 4.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BORR
3451
Borr Drilling
BORR
$1.23B
| $806K | ﹤0.01% |
216,362
-68,512
| -24% | -$292K |
|
3452
CALL
CRISPR Therapeutics
CRSP
$4.77B
| $803K | ﹤0.01% |
+20,400
| New | +$963K |
|
|
3453
PUT
CRISPR Therapeutics
CRSP
$4.77B
| $803K | ﹤0.01% |
+20,400
| New | +$963K |
|
|
ADAM
3454
Adamas Trust
ADAM
$803M
| $801K | ﹤0.01% |
132,240
-114,217
| -46% | -$671K |
|
3455
Thryv Holdings
THRY
$180M
| $800K | ﹤0.01% |
54,039
+14,647
| +37% | +$231K |
|
|
PLYM
3456
DELISTED
Plymouth Industrial REIT
PLYM
| $799K | ﹤0.01% |
44,896
+6,192
| +16% | +$122K |
|
3457
iShares MSCI USA Equal Weighted ETF
EUSA
$1.82B
| $798K | ﹤0.01% |
8,368
-11,412
| -58% | -$1.12M |
|
3458
Rayonier
RYN
$6.43B
| $795K | ﹤0.01% |
31,933
+12,979
| +68% | +$361K |
|
|
THR
3459
DELISTED
Thermon Group Holdings
THR
| $792K | ﹤0.01% |
27,534
+3,254
| +13% | +$95.8K |
|
3460
BrightSpring Health Services
BTSG
$14.3B
| $792K | ﹤0.01% |
46,515
+7,668
| +20% | +$133K |
|
3461
BlueLinx
BXC
$416M
| $791K | ﹤0.01% |
7,740
+736
| +11% | +$84.3K |
|
3462
iShares Morningstar Value ETF
ILCV
$1.32B
| $789K | ﹤0.01% |
9,741
+95
| +1% | +$7.88K |
|
3463
IDT Corp
IDT
$1.64B
| $784K | ﹤0.01% |
16,494
-1,780
| -10% | -$85.4K |
|
3464
Clearwater Paper
CLW
$341M
| $784K | ﹤0.01% |
26,328
+2,789
| +12% | +$75.7K |
|
3465
Ginkgo Bioworks
DNA
$528M
| $780K | ﹤0.01% |
79,460
+50,609
| +175% | +$434K |
|
3466
iShares Intermediate Government/Credit Bond ETF
GVI
$3.78B
| $780K | ﹤0.01% |
7,485
+5,602
| +298% | +$589K |
|
3467
iShares MSCI ACWI ex US ETF
ACWX
$11.5B
| $778K | ﹤0.01% |
14,909
+11,207
| +303% | +$613K |
|
3468
PMV Pharmaceuticals
PMVP
$60.3M
| $778K | ﹤0.01% |
514,911
-4
| -0% | -$6 |
|
3469
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.1B
| $777K | ﹤0.01% |
26,790
-1,524
| -5% | -$44.3K |
|
3470
Galicia Financial Group
GGAL
$8.29B
| $776K | ﹤0.01% |
12,447
+5,731
| +85% | +$315K |
|
3471
GCM Grosvenor
GCMG
$751M
| $776K | ﹤0.01% |
63,208
+32,345
| +105% | +$384K |
|
3472
Krispy Kreme
DNUT
$553M
| $775K | ﹤0.01% |
78,059
+8,460
| +12% | +$91.6K |
|
3473
Eldorado Gold
EGO
$8.53B
| $775K | ﹤0.01% |
52,108
+18,313
| +54% | +$302K |
|
3474
Hingham Institution for Saving
HIFS
$622M
| $773K | ﹤0.01% |
3,041
+395
| +15% | +$105K |
|
3475
GDS Holdings
GDS
$6.41B
| $771K | ﹤0.01% |
32,439
-146,926
| -82% | -$3.1M |
|
Similar funds
Citigroup's Q4 2024 Portfolio in Review
As of Q4 2024, Citigroup held 6,077 positions worth $169B, down 2.4% from $173B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Citigroup withdrew a net $7.85B in Q4 2024, closing 263 positions and reducing 1,533 holdings. Its most notable exit was Stericycle Inc, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, Citigroup opened a new position in T-Rex 2X Long MSTR Daily Target ETF worth $19M.
- Citigroup's largest Q4 2024 buy was T-Rex 2X Long MSTR Daily Target ETF: 249,467 shares worth $19M.
- Citigroup added most to Jefferies Financial Group in Q4 2024, an estimated $460M increase.
- Citigroup's biggest Q4 2024 reduction was Caterpillar, cutting an estimated $755M.
- Citigroup fully exited Stericycle Inc in Q4 2024, selling an estimated $125M.
- Citigroup's ten largest holdings make up 21% of its $169B portfolio in Q4 2024.
- Citigroup opened 429 new positions and closed 263 in Q4 2024.
- Citigroup's portfolio value fell 2.4% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q4 2024, filed 12 Feb 2025.